Online citations, reference lists, and bibliographies.
← Back to Search

Lipophilic Peptide Character - What Oral Barriers Fear The Most.

O. Zupančič, A. Bernkop-Schnürch
Published 2017 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Peptide therapeutics is currently one of the fastest growing markets worldwide and consequently convenient ways of administration for these drugs are highly on demand. In particular, oral dosage forms would be preferred. A relative large molecular weight and high hydrophilicity, however, result in comparatively very low oral bioavailability being in most cases below 1%. Lipid based formulations (LBF), in particular self-emulsifying drug delivery systems (SEDDS) and solid lipid nanoparticles (SLN) as well as liposomes are among the most promising tools for oral peptide delivery. Key to success in orally delivering peptides via LBF seems to be a sufficiently high lipophilic character of those therapeutic agents. Hence, different non-covalent and covalent peptide lipidization methods from drug delivery point of view are presented. On the one hand, among non-covalent lipidization methods hydrophobic ion pairing seems to be a promising way to sufficiently increase peptide lipophilicity providing high drug payloads in the lipid phase, a protective effect against presystemic metabolism via thiol-disulphide exchange reactions and proteolysis as well as an improved intestinal membrane permeability. On the other hand, covalent methods like conjugating fatty acids via amidation, esterification, reversible aqueous lipidization (REAL) and cyclization also show potential. The present review therefore describes those lipidization methods in detail and critically evaluates their contribution in successfully overcoming the oral barriers.
This paper references
10.3109/10717544.2016.1157840
Hypoglycemic activity and stability enhancement of human insulin–tat mixture loaded in elastic anionic niosomes
A. Manosroi (2016)
10.1007/s11051-014-2420-4
One-pot aqueous synthesis of cysteine-capped CdTe/CdS core–shell nanowires
Y. Shan (2014)
10.1042/BJ3110341
Identification of histatins as tannin-binding proteins in human saliva.
Q. Yan (1995)
10.1111/j.1939-1676.2009.0342.x
Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
R. Nelson (2009)
10.1016/j.msec.2014.10.070
Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes.
Saeid Moghassemi (2015)
10.1016/S0003-9969(98)00040-5
Interaction of tannin with human salivary proline-rich proteins.
Y. Lu (1998)
10.3109/02652048.2014.885606
A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation
Ashaben Patel (2014)
10.1016/j.peptides.2010.02.017
A palmitoyl conjugate of insect pentapeptide Yamamarin arrests cell proliferation and respiration
Y. Sato (2010)
10.1002/jps.23640
Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems.
P. Li (2013)
10.1016/S0196-9781(01)00537-X
Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability
K. Witt (2001)
10.1002/JPS.10573
Biodegradable nanoparticles containing protein‐fatty acid complexes for oral delivery of salmon calcitonin
H. Yoo (2004)
10.1021/mp9002688
Diabetes correction in pancreatectomized canines by orally absorbable insulin-deoxycholate complex.
S. K. Kim (2010)
10.1016/S0927-7765(02)00053-X
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M. Garcia-Fuentes (2003)
10.1016/J.TET.2005.08.031
Amide bond formation and peptide coupling
C. Montalbetti (2005)
10.1021/JM9608669
Angiotensin analogues palmitoylated in positions 1 and 4.
L. Maletínská (1997)
10.1046/j.1462-5822.2003.00338.x
From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1‐DD/ISCOM
N. Lycke (2004)
Preparation and properties of buserelin suspensions.
F. Ryszka (1994)
10.1016/j.ijpharm.2014.10.039
Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
P. Li (2014)
10.1021/mp500809f
Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs.
J. Wang (2015)
10.1023/A:1016472119387
Esterase-Sensitive Cyclic Prodrugs of Peptides: Evaluation of an Acyloxyalkoxy Promoiety in a Model Hexapeptide
G. Pauletti (2004)
10.1248/CPB.51.759
Synthesis and antinociceptive activity of orally active opioid peptides: improvement of oral bioavailability by esterification.
T. Ogawa (2003)
10.1002/BIP.360330608
Enhanced solubility of proteins and peptides in nonpolar solvents through hydrophobic ion pairing
M. Powers (1993)
10.1016/j.nano.2013.07.011
Biotinylated liposomes as potential carriers for the oral delivery of insulin.
X. Zhang (2014)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
10.1039/CS9932200085
POLYMER MICELLE INTERACTIONS - PHYSICAL ORGANIC ASPECTS
J. Brackman (1993)
10.1021/JA0563455
Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers.
T. Rezai (2006)
10.1021/CR0301402
Macrolactonizations in the total synthesis of natural products.
A. Parenty (2006)
10.1155/2011/458128
Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles
Ripal Gaudana (2011)
10.1016/S0939-6411(98)00008-3
Sustained release of injectable zinc-recombinant hirudin suspensions: development and validation of in vitro release model.
U. Gietz (1998)
10.1016/j.ijpharm.2009.01.022
Evaluation of pharmacological efficacy of 'insulin-surfoplex' encapsulated polymer vesicles.
R. Rastogi (2009)
10.1016/j.xphs.2017.01.019
Storage Stability of Bivalirudin: Hydrophilic Versus Lipophilic Solutions.
O. Zupančič (2017)
10.1038/sj.bjp.0702990
Lipophilization of somatostatin analog RC‐160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro
P. Dasgupta (2000)
10.1021/mp700126c
Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine.
W. Chen (2008)
10.1021/JA954217I
Solution Structures of i to i + 3 Cyclized Model Peptides: Building Blocks Mimicking Specific Conformations
H. R. Marepalli (1996)
10.1016/j.jconrel.2014.08.004
Pre-systemic metabolism of orally administered drugs and strategies to overcome it.
I. Pereira de Sousa (2014)
10.1016/j.jmb.2009.06.019
The role of decorated SDS micelles in sub-CMC protein denaturation and association.
K. Andersen (2009)
10.1517/17425247.2015.1068287
Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery
G. Leonavičiūtė (2015)
10.1038/SCIBX.2012.1176
Bringing macrocycles full circle
Joanne D Kotz (2012)
10.1002/jps.21524
Synthesis, characterization and in vivo activity of salmon calcitonin coconjugated with lipid and polyethylene glycol.
W. Cheng (2009)
10.1023/A:1011998014474
Hydrophobic Ion Pairing: Altering the Solubility Properties of Biomolecules
J. D. Meyer (2004)
10.1016/j.colsurfb.2008.12.031
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
Hong Yuan (2009)
10.1016/j.addr.2012.07.012
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.
Michael J. Hackett (2013)
10.1517/13543776.10.9.1357
The use of multifunctional polymers for non-invasive peptide and protein application
A. Bernkop-Schnürch (2000)
10.2174/1389450117666151209120139
Delivery of Therapeutic Proteins: Challenges and Strategies.
K. Rehman (2016)
10.1016/j.addr.2016.01.010
Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts.
E. Moroz (2016)
10.1016/j.ejpb.2014.06.011
Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
T. Fan (2014)
10.1016/J.JCONREL.2004.03.010
Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery.
Y. Onuki (2004)
10.1016/j.ejpb.2010.12.008
In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery.
Abdallah Makhlof (2011)
10.1016/j.ijpharm.2011.08.029
Preliminary evaluation of a novel oral delivery system for rhPTH1-34: in vitro and in vivo.
L. Guo (2011)
Pulsatile and sustained peptides release from Zn(II) suspensions.
F. Ryszka (2003)
10.1007/s11095-006-9128-9
Aqueous-Soluble, Non-Reversible Lipid Conjugate of Salmon Calcitonin: Synthesis, Characterization and In Vivo Activity
W. Cheng (2006)
10.1016/S0928-0987(00)00072-5
Formulation of sustained release aqueous Zn-hirudin suspensions.
U. Gietz (2000)
10.1080/10611860600648221
Reversible lipidization for the oral delivery of leu-enkephalin
J. Wang (2006)
10.15230/SCSK.2016.42.2.135
Stability of Various Liposome Formulation Containing the Phytochemical-Peptide Derivatives
Byung Seok Han (2016)
10.1080/03639045.2017.1338722
Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery
O. Zupančič (2017)
10.1016/j.ejps.2015.10.005
Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin.
O. Zupančič (2016)
10.1016/s0169-409x(96)00423-1
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
C. Lipinski (2001)
10.1038/nchem.1062
Contemporary strategies for peptide macrocyclization.
C. J. White (2011)
10.1021/jp810342s
Optical properties of isolated hormone oxytocin dianions: ionization, reduction, and copper complexation effects.
L. Joly (2009)
10.1016/0005-2795(79)90088-6
Precipitation of egg white proteins below their isoelectric points by sodium dodecyl sulphate and temperature.
P. O. Hegg (1979)
10.1023/A:1018927402875
Formulation and Intestinal Absorption Enhancement Evaluation of Water-in-Oil Microemulsions Incorporating Medium-Chain Glycerides
P. Constantinides (2004)
Lipophilicity--methods of determination and its role in medicinal chemistry.
Ewelina E Rutkowska (2013)
10.1007/978-94-010-0464-0_291
Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units.
S. Gazal (2002)
10.1021/ja076849y
Synthesis, characterization, and application of iodoacetamide derivatives utilized for the ALiPHAT strategy.
D. Williams (2008)
10.1023/A:1012076022420
Applications of the Ion-Pair Concept to Hydrophilic Substances with Special Emphasis on Peptides
D. Quintanar-Guerrero (2004)
10.2147/IJN.S36071
Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs
Hongwu Sun (2012)
10.3109/00365529109003954
Regional variations in total and nonprotein sulfhydryl compounds in the human gastric mucosa and effects of ethanol.
C. Loguercio (1991)
10.1023/A:1018928613837
Stability of Acyl Derivatives of Insulin in the Small Intestine: Relative Importance of Insulin Association Characteristics in Aqueous Solution
Hiroyuki Asada (2004)
10.1021/JA00057A006
Structure and stability of insulin dissolved in 1-octanol
J. Matsuura (1993)
10.1016/j.ijpharm.2017.02.019
Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems.
J. Griesser (2017)
10.1002/JMS.1157
LC/MS characterization of undesired products formed during iodoacetamide derivatization of sulfhydryl groups of peptides.
Zhihua Yang (2007)
10.4049/jimmunol.167.6.3398
CTA1-DD-Immune Stimulating Complexes: a Novel, Rationally Designed Combined Mucosal Vaccine Adjuvant Effective with Nanogram Doses of Antigen1
A. Mowat (2001)
10.1016/j.addr.2009.11.012
Nanotechnology solutions for mucosal immunization.
S. Chadwick (2010)
10.1016/j.ejpb.2013.07.017
Solid lipid particles for oral delivery of peptide and protein drugs I--elucidating the release mechanism of lysozyme during lipolysis.
P. C. Christophersen (2013)
10.1111/J.1432-1033.1987.TB10615.X
Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure.
R. Orlowski (1987)
10.1007/BF02973888
Multivesicular liposomes for oral delivery of recombinant human epidermal growth factor
H. Li (2005)
10.1016/j.ejpb.2015.11.003
Mucoadhesive vs. mucopenetrating particulate drug delivery.
Kesinee Netsomboon (2016)
10.1016/j.ejpb.2016.09.013
Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
O. Zupančič (2016)
10.1016/S0006-291X(03)01028-3
Solution structure and biological activity of recombinant salmon calcitonin S-sulfonated analog.
Yuefeng Wang (2003)
10.1023/A:1018802324759
Phenylpropionic Acid-Based Cyclic Prodrugs of Opioid Peptides that Exhibit Metabolic Stability to Peptidases and Excellent Cellular Permeation
O. S. Gudmundsson (2004)
10.1016/j.jconrel.2008.03.014
Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugs.
Liyun Yuan (2008)
10.1021/JA046042V
Oxytocin-receptor binding: why divalent metals are essential.
Dengfeng Liu (2005)
10.2147/IJN.S25824
Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex
Jinjie Zhang (2011)
10.2147/IJN.S31711
Solid lipid nanoparticles modified with stearic acid–octaarginine for oral administration of insulin
Z. Zhang (2012)
10.1016/S0014-827X(02)00020-4
Preparation and properties of selected Zn(II)-peptide complexes in suspension.
B. Dolińska (2003)
10.1023/A:1018973029651
Prodrugs of Peptides. 18. Synthesis and Evaluation of Various Esters of Desmopressin (dDAVP)
A. H. Kahns (2004)
10.1016/j.jconrel.2008.03.018
Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
Mao-Bo Cheng (2008)
10.1186/1472-6904-8-5
Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: The effect of water and timing of meal intake on oral delivery of Salmon Calcitonin
M. Karsdal (2008)
10.1016/j.ijpharm.2012.10.025
Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.
Shunwen Hu (2013)
10.3109/02652048.2015.1035685
Oral self-nanoemulsifying peptide drug delivery systems: impact of lipase on drug release
R. Mahjub (2015)
10.1039/CS9922100127
Surfactant interactions with biomembranes and proteins
M. Jones (1992)
10.1002/1520-6017(200102)90:2<194::AID-JPS10>3.0.CO;2-Q
Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles.
H. Yoo (2001)
10.1016/j.drudis.2014.10.003
Peptide therapeutics: current status and future directions.
K. Fosgerau (2015)
10.2174/092986712799945003
Converting peptides into drug leads by lipidation.
L. Zhang (2012)
10.1021/bm401580k
Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.
A. Agrawal (2014)
10.1208/s12248-011-9307-4
Absorption Enhancers: Applications and Advances
B. Aungst (2011)
10.1007/s00726-005-0241-6
Characterisation of the thiol–disulphide chemistry of desmopressin by LC, μ-LC, LC-ESI-MS and Maldi-Tof
T. Schmitz (2005)
10.2217/nnm.12.141
Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.
Chunhui Chen (2013)
10.1016/j.ddtec.2011.11.006
Overcoming poor permeability: translating permeation enhancers for oral peptide delivery.
S. Maher (2012)
10.1111/j.1745-7254.2006.00424.x
In vitro and in vivo evaluation of a novel oral insulin formulation
Er-li Ma (2006)
10.1016/j.ijpharm.2008.05.016
Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: II. In vitro transport study.
S. V. R. Rao (2008)
10.1023/A:1018929312715
Preparation, Purification, and Characterization of a Reversibly Lipidized Desmopressin with Potentiated Anti-Diuretic Activity
J. Wang (2004)
10.1016/S0168-3659(97)00204-6
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.
A. Bernkop-Schnürch (1998)
10.1016/j.ejpb.2015.04.013
Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems.
T. Karamanidou (2015)
10.1210/ENDO.142.1.7880
Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
M. Afargan (2001)
10.1016/j.ejpb.2010.09.002
In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.
J. Parmentier (2010)
10.1002/JPS.2600760709
Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.
C. Mcmartin (1987)
10.1248/CPB.58.1195
Preparation of gel-core-solid lipid nanoparticle: a novel way to improve the encapsulation of protein and peptide.
R. Yang (2010)
10.1080/17425247.2016.1213236
Cell-penetrating self-nanoemulsifying drug delivery systems (SNEDDS) for oral gene delivery
A. Mahmood (2016)
10.1007/s11095-010-0130-x
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
G. Fricker (2010)
10.1023/A:1015992828666
Synthesis of Palmitoyl Derivatives of Insulin and Their Biological Activities
M. Hashimoto (2004)
10.1023/A:1018935800052
Lipophilization of Somatostatin Analog RC-160 Improves Its Bioactivity and Stability
P. Dasgupta (2004)
10.1016/j.ejps.2009.02.004
Lipeo-sCT: a novel reversible lipidized salmon calcitonin derivative, its biophysical properties and hypocalcemic activity.
W. Cheng (2009)
10.1016/j.bbrc.2010.03.041
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
10.1046/j.1365-2710.2000.00306.x
Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro‐in vivo evaluation
S. T. Dogru (2000)
10.1016/j.ijpharm.2008.05.018
Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development.
S. V. R. Rao (2008)
10.3109/10717544.2011.577108
Development and in vivo evaluation of a new oral nanoparticulate dosage form for leuprolide based on polyacrylic acid
J. Iqbal (2011)
10.1016/j.ejps.2016.06.011
Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant.
P. Bu (2016)
10.1016/S0168-3659(02)00165-7
Modifying the release of leuprolide from spray dried OED microparticles.
R. Alcock (2002)
10.1016/J.IJPHARM.2004.10.014
Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique.
M. Trotta (2005)
10.1007/s00726-005-0289-3
Strategies to improve plasma half life time of peptide and protein drugs
M. Werle (2005)
10.1002/HLCA.19960790723
Lipid Masking and Reactivation of Angiotensin Analogues
L. Maletínskâ (1996)
10.1042/BJ3120725
Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo.
P. Kurtzhals (1995)
10.1016/j.ijpharm.2013.02.030
Approaches for enhancing oral bioavailability of peptides and proteins.
J. Renukuntla (2013)
10.1155/2012/474605
Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy
Juliana de Souza Rebouças (2012)
10.2174/138920007780866834
Presystemic metabolism of orally administered peptide drugs and strategies to overcome it.
A. Bernkop-Schnürch (2007)
10.1021/BI00626A028
Crystallographic studies of protein denaturation and renaturation. 2. Sodium dodecyl sulfate induced structural changes in triclinic lysozyme.
A. Yonath (1977)
10.1016/0014-5793(95)00910-2
Water‐soluble fatty acid derivatives as acylating agents for reversible lipidization of polypeptides
H. Ekrami (1995)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1021/CB700186X
Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target.
O. A. Timofeeva (2007)
10.3109/10717544.2016.1143056
Development and in vitro evaluation of an oral SEDDS for desmopressin
O. Zupančič (2016)
10.1016/j.ijpharm.2014.05.047
In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
Fabian Hintzen (2014)
10.1023/A:1016078118033
Comparison of Pharmacokinetic Parameters of a Polypeptide, the Bowman-Birk Protease Inhibitor (BBI), and Its Palmitic Acid Conjugate
L. Honeycutt (2004)
10.1016/j.ijpharm.2015.04.075
Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.
Ravi Vaishya (2015)
10.1016/j.addr.2016.04.001
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
10.1016/j.drudis.2013.05.011
Future directions for peptide therapeutics development.
Allan A. Kaspar (2013)
10.1208/s12248-014-9687-3
Strategic Approaches to Optimizing Peptide ADME Properties
Li Di (2014)
10.1016/j.ijpharm.2008.05.015
Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
S. V. R. Rao (2008)
10.1016/S0378-5173(00)00457-9
Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres.
S. Choi (2000)
10.1016/S0378-5173(01)00600-7
A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ionic species.
S. Prabhu (2001)
10.1021/JM00076A002
Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations.
N. El Tayar (1993)
10.1016/0169-409X(92)90005-B
(D) Routes of delivery: Case studies
P. Smith (1992)
Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids.
E. Yodoya (1994)
10.1016/J.IJPHARM.2006.07.026
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
N. Zhang (2006)
10.1021/mp8000167
Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
W. Cheng (2008)
10.1021/JF981370Y
Interaction of Alkylsulfonate Ligands with β-Lactoglobulin AB from Bovine Milk
P. Busti (1999)
10.1016/j.ijpharm.2013.11.028
Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study.
M. Niu (2014)
10.1016/j.addr.2008.09.008
Barrier properties of mucus.
Richard A. Cone (2009)
10.1016/j.ijpharm.2009.12.008
Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex.
P. Yue (2010)
10.1016/J.IJPHARM.2005.01.018
Investigation of lectin-modified insulin liposomes as carriers for oral administration.
N. Zhang (2005)
10.1016/j.ijpharm.2011.05.066
Oral peptide delivery by tetraether lipid liposomes.
J. Parmentier (2011)
10.1016/j.bbapap.2011.03.003
Protein-surfactant interactions: a tale of many states.
D. Otzen (2011)
10.1016/J.JCONREL.2006.05.013
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
F. Cui (2006)
10.1016/j.ijpharm.2012.03.056
Oral delivery of therapeutic protein/peptide for diabetes--future perspectives.
M. Rekha (2013)
10.1016/j.colsurfb.2014.02.045
Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles.
Rahul S. Kalhapure (2014)
10.1023/A:1011997404306
Permeability Characteristics of Tetragastrins Across Intestinal Membranes Using the Caco-2 Monolayer System: Comparison Between Acylation and Application of Protease Inhibitors
T. Fujita (2004)
10.1023/A:1018828207920
Coumarinic Acid-Based Cyclic Prodrugs of Opioid Peptides that Exhibit Metabolic Stability to Peptidases and Excellent Cellular Permeability
O. S. Gudmundsson (2004)
10.1023/A:1018854308829
Acyloxyalkoxy-Based Cyclic Prodrugs of Opioid Peptides: Evaluation of the Chemical and Enzymatic Stability as Well as Their Transport Properties Across Caco-2 Cell Monolayers
A. Bak (2004)
10.1007/s11051-014-2293-6
PEG-stearate coated solid lipid nanoparticles as levothyroxine carriers for oral administration
S. Kashanian (2014)
10.1016/S0021-9797(02)00017-6
Protective effect of small amounts of sodium dodecyl sulfate on the helical structure of bovine serum albumin in thermal denaturation.
Yoshiko Moriyama (2003)
10.1021/mp300009u
A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain.
A. Lalatsa (2012)
10.1166/JBN.2012.1371
The in vitro and in vivo study on self-nanoemulsifying drug delivery system (SNEDDS) based on insulin-phospholipid complex.
Q. Zhang (2012)
10.1016/j.joca.2009.08.004
The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.
M. Karsdal (2010)
10.1023/A:1015397811161
Structure-Activity Relationship of Reversibly Lipidized Peptides: Studies of Fatty Acid-Desmopressin Conjugates
J. Wang (2004)
10.1021/mp500475y
Influence of microemulsion-mucin interaction on the fate of microemulsions diffusing through pig gastric mucin solutions.
J. Zhang (2015)
10.1016/j.ijpharm.2016.04.044
Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases.
G. Leonavičiūtė (2016)
10.1016/j.ijpharm.2015.03.064
Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery.
S. Hauptstein (2015)
10.3109/10837450.2012.737806
Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme
Ripal Gaudana (2013)
10.1002/PSC.66
Current Concepts in Intestinal Peptide Absorption
G. Fricker (1996)
10.1038/KI.1975.116
Role of the disulfide bridge and the C-terminal tripeptide in the antidiuretic action of vasopressin in man and the rat.
J. Cort (1975)
10.1016/S0168-3659(99)00231-X
Oral vaccine delivery.
G. Russell-Jones (2000)
10.1021/LA00084A009
POLYMER NONIONIC MICELLE COMPLEXATION - FORMATION OF POLY(PROPYLENE OXIDE)-COMPLEXED N-OCTYL THIOGLUCOSIDE MICELLES
J. Brackman (1988)
10.1016/J.IJPHARM.2006.11.035
Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing.
Wei-guo Dai (2007)
10.1034/J.1399-3011.1999.00071.X
Synthesis and evaluation of the physicochemical properties of esterase-sensitive cyclic prodrugs of opioid peptides using coumarinic acid and phenylpropionic acid linkers.
B. Wang (1999)
10.2217/NNM-2016-0265
Lipid-based nanocarriers for the oral administration of biopharmaceutics.
T. Karamanidou (2016)
10.1080/01635589409514302
Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level.
E. Flagg (1994)
In vitro and in vivo evaluation of a novel oral insulin formulation 1
H Ma (2006)
10.1016/j.ijpharm.2009.06.014
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
S. Salmaso (2009)
10.1016/S0021-9673(01)94682-5
Measurement of lipophilicity by high performance liquid chromatography comparison with calculated lipophilicity values
J. Sabatka (1987)
10.1016/J.IJPHARM.2005.06.028
Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
H. Takeuchi (2005)
10.1111/j.1939-1676.2011.00861.x
Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
A. D. Maggiore (2012)
10.3109/03639045.2010.497151
The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process
R. Yang (2011)
10.1016/j.ijpharm.2011.01.003
Protamine modified metal ion-protein chelate microparticles for sustained release of interferon.
Yanbo Jiang (2011)
10.1517/17425240903018863
Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators
Pernille Nordly (2009)
10.1136/gut.50.2.235
Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system
H. Hoensch (2002)
10.1517/17425247.2016.1167034
Development of oral self nano-emulsifying delivery system(s) of lanreotide with improved stability against presystemic thiol-disulfide exchange reactions
M. Ijaz (2016)
10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
10.1002/QSAR.19890080104
Model Solvent Systems for QSAR Part I. Propylene Glycol Dipelargonate (PGDP). A new Standard Solvent for use in Partition Coefficient Determination
D. Leahy (1989)
10.4155/TDE.11.128
Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies.
B. Griffin (2011)
10.1016/J.JCONREL.2007.07.013
Liphophilic complexation of heparin based on bile acid for oral delivery.
D. Lee (2007)
10.1080/10611860600648346
The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin
J. Thongborisute (2006)
10.1038/nrd1067
Challenges for the oral delivery of macromolecules
M. Goldberg (2003)
10.1016/S0168-3659(03)00008-7
Reversible lipidization for the oral delivery of salmon calcitonin.
J. Wang (2003)
10.1016/j.ejpb.2010.07.002
Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats.
G. Sharma (2010)
10.1529/BIOPHYSJ.105.065342
Interactions between charged polypeptides and nonionic surfactants.
H. Sjögren (2005)
10.1021/jp9037478
Optical and structural properties of copper-oxytocin dications in the gas phase.
L. Joly (2009)
10.5530/IJPER.48.3.6
Structural Modification of Proteins and Peptides
A. Mahajan (2014)
10.1016/S0196-9781(97)00474-9
Efficacy of Oral Dalargin-loaded Nanoparticle Delivery across the Blood–Brain Barrier
U. Schroeder (1998)
10.2217/nnm.13.178
Strategies for improving mucosal drug delivery.
Flavia Laffleur (2013)
10.1016/j.addr.2009.09.006
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
S. Maher (2009)
10.1016/J.IJPHARM.2006.09.025
Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats.
K. Maiti (2007)
10.1007/s11095-014-1337-z
Solid Lipid Particles for Oral Delivery of Peptide and Protein Drugs II – The Digestion of Trilaurin Protects Desmopressin from Proteolytic Degradation
P. C. Christophersen (2014)
10.1016/0168-3659(92)90075-3
Trials of lipid modification of peptide hormones for intestinal delivery
S. Muranishi (1992)
10.1016/j.ejpb.2009.06.004
Formulation and characterization of an oily-based system for oral delivery of insulin.
A. Elsayed (2009)
10.1016/j.drudis.2009.10.009
Synthetic therapeutic peptides: science and market.
P. Vlieghe (2010)
10.1081/DDC-120021771
Double Liposomes: Hypoglycemic Effects of Liposomal Insulin on Normal Rats
Ken Katayama (2003)
10.1016/j.ijpharm.2010.03.061
Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins.
Vellore J. Mohanraj (2010)
10.1007/s11095-004-1189-z
Reversible Lipidization Prolongs the Pharmacological Effect, Plasma Duration, and Liver Retention of Octreotide
Liyun Yuan (2004)
10.1002/JPS.2600840604
Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.
H. Asada (1995)
10.4018/978-1-5225-0751-2.CH004
Non-Ionic Surfactant Vesicles (Niosomes) as New Drug Delivery Systems
A. Pardakhty (2017)



This paper is referenced by
10.1016/j.ijpharm.2019.03.001
Self‐emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release
Imran Nazir (2019)
10.1016/j.jconrel.2018.01.012
Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs
S. Bonengel (2018)
10.1016/j.jcis.2018.01.082
Surface phosphorylation of nanoparticles by hexokinase: A powerful tool for cellular uptake improvement.
Imran Nazir (2018)
10.2217/nnm-2017-0307
Amikacin-containing self-emulsifying delivery systems via pulmonary administration for treatment of bacterial infections of cystic fibrosis patients.
G. Hetényi (2018)
10.3390/md18080390
Advances in the Study of Marine Products with Lipid-Lowering Properties
J. Zhao (2020)
10.1016/j.jconrel.2019.05.011
Hydrophobic ion-pairs and lipid-based nanocarrier systems: The perfect match for delivery of BCS class 3 drugs.
Thị Như Quỳnh Phan (2019)
10.1039/C7RA13102J
Preventive effect of goby fish protein hydrolysates on hyperlipidemia and cardiovascular disease in Wistar rats fed a high-fat/fructose diet
R. Nasri (2018)
Self- emulsifying drug delivery systems (SEDDS): new hope in the heart of orally delivered macromolecules
(2017)
10.1016/j.xphs.2018.02.012
Labrasol® and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae.
Joanne Heade (2018)
10.1016/j.ijpharm.2020.119918
Storage stability of proteins in a liquid-based formulation: liquid vs. solid self-emulsifying drug delivery.
Haniyeh Etezadi (2020)
10.3390/pharmaceutics11010041
Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update
S. Maher (2019)
10.1080/17425247.2021.1825375
Intestinal permeation enhancers to improve oral bioavailability of macromolecules: Reasons for low efficacy in humans.
S. Maher (2020)
10.1016/j.ijpharm.2018.11.010
Development and in vitro evaluation of a self‐emulsifying drug delivery system (SEDDS) for oral vancomycin administration
S. Zaichik (2019)
10.1002/mabi.201700060
A Polymer Chemistry Point of View on Mucoadhesion and Mucopenetration.
Philipp S. Schattling (2017)
10.2478/acph-2018-0032
Effect of surface hydrophobicity of therapeutic protein loaded in polyelectrolyte nanoparticles on transepithelial permeability
Ana Miklavžin (2018)
10.1016/j.jconrel.2018.03.018
In vivo evaluation of an oral self‐emulsifying drug delivery system (SEDDS) for exenatide
Claudia Menzel (2018)
10.3390/nano9030474
Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs
Laura Bayón-Cordero (2019)
10.1016/j.ijpharm.2019.118863
Hydrophobic H-bond pairing: A novel approach to improve membrane permeability.
Imran Nazir (2019)
10.1016/J.CCLET.2018.05.027
Methods for engineering therapeutic peptides
Yaohao Li (2018)
10.1007/s40005-017-0374-0
Peptides as drug delivery vehicles across biological barriers
D. Ghosh (2017)
10.1080/1061186X.2019.1584200
Oral self-emulsifying delivery systems for systemic administration of therapeutic proteins: science fiction?
Thị Như Quỳnh Phan (2019)
10.1016/j.ijpharm.2018.02.038
Lipid-based nanosuspensions for oral delivery of peptides, a critical review.
Camille Dumont (2018)
Semantic Scholar Logo Some data provided by SemanticScholar